Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)- 2H-pyrano[3,2-g]quinolin-2-one

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 7, 1999, Pages 1003-1008

  Edwards, James P ^a   Higuchi, Robert I ^a   Winn, David T ^a   Pooley, Charlotte L F ^a   Caferro, Thomas R ^a   Hamann, Lawrence G ^a   Zhi, Lin ^a   Marschke, Keith B ^a   Goldman, Mark E ^a   Jones, Todd K ^a  

^a Department Medicinal Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (TRIFLUOROMETHYL) 2H PYRANO[3,2 G]QUINOLIN 2 ONE; ANDROGEN RECEPTOR; ANDROSTANOLONE; BICALUTAMIDE; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; LG 120907; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CERCOPITHECIDAE; CROSS REACTION; GENETIC TRANSCRIPTION; NONHUMAN; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALS; BENZOPYRANS; CELL LINE; COS CELLS; HUMANS; QUINOLONES; RECEPTORS, ANDROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; CERCOPITHECIDAE;

EID: 0033526028     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00118-3     Document Type: Article

References (29)

1. 1. Current Address: The R.W. Johnson Pharmaceutical Research Institute, 3535 General Atomics Ct., San Diego, CA 92121, USA.
2. 2. Current Address: Idun Pharmaceuticals, 11085 N. Torrey Pines Road, La Jolla, CA 92037, USA.
3. 3. Current Address: Axiom Biotechnologies, 3550 General Atomics Court, San Diego, CA 92121, USA.
4. 4. Current address: Ontogen Corporation, 2325 Camino Vida Roble, Carlsbad, CA 92009.
5. 5. Hamann, L. G.; Higuchi, R. I.; Zhi, L.; Edwards, J. P.; Wang, X.-N.; Marschke, K. B.; Kong, J.; Farmer, L. J.; Jones, T. K. J. Med. Chem., 1998, 41, 623.
6. 6. For leading references to the family of closely related intracellular receptors to which the androgen receptor belongs, see: (a) McDonnell, D. P.; Vegeto, E.; Gleeson, M. A. G. Bio/Technology 1993, 11, 1256.
7. (b) Rosen, J.; Day, A.; Jones, T. K.; Jones, E. T. T.; Nadzan, A. M.; Stein, R. B. J. Med. Chem. 1995, 38, 4855.
8. 7. (a) Neri, R.; Peets, E.; Watnick, A. Biochem. Soc. Trans. 1979, 7, 565.
9. (b) Neri, R.; Peets, E. A. J. Steroid Biochem. 1975, 6, 815.
10. 8. (a) Kaisary, A. V. Prostate Suppl. 1994, 5, 27.
11. (b) Lungimayr, G. Anti-Cancer Drugs 1995, 6, 508.
12. 9. (a) Tenover, J. S. J. Clin. Endocrinol. Metab. 1992, 75, 1092.
13. (b) Bhasin, S. J. Clin. Endocrinol. Metab. 1992, 74, 1221.
14. (c) Bhasin, S.; Bremner, W. J. J. Clin. Endocrinol. Metab. 1997, 82, 3.
15. 10. (a) Edwards, J. P.; West, S. J.; Pooley, C. L. F.; Marschke, K. B.; Farmer, L. J.; Jones, T. K. Bioorg. Med. Chem. Lett. 1998, 8, 745.
16. (b) Dalton, J. T.; Mukherjee, A.; Zhu, Z.; Kirkovsky, L.; Miller, D. D. Biochem. Biophysical Res. Commun. 1998, 244, 1.
17. 11. Berger, T. S.; Parandoosh, Z.; Perry, B. W.; Stein, R. B. J. Steroid Biochem. Mol. Biol. 1992, 41, 733.
18. 12. See: (a) Pooley, C. L. F.; Edwards, J. P.; Goldman, M. E.; Wang, M.-W.; Marschke, K. B.; Crombie, D. L.; Jones, T. K. J. Med. Chem. 1998, 41, 3461.
19. (b) Hamann, L. G.; Winn, D. T.; Pooley, C. L. F.; Tegley, C. M.; West, S. J.; Farmer, L. J.; Zhi, L.; Edwards, J. P.; Marschke, K. B.; Mais, D. E.; Goldman, M. E.; Jones, T. K. Bioorg. Med. Chem. Lett. 1998, 8, 2731, and references therein.
20. 13. Manske, R. H. F.; Kulka, M. Org. React. 1953, 7, 59.
21. 14. Imada, Y.; Yuasa, M.; Nakamura, I.; Murahashi, S.-I. J. Org. Chem. 1994, 59, 2282.
22. 15. Eason, N. R.; Cassady., D. R. J. Org. Chem. 1962, 27, 4713.
23. 16. Sethna, S.; Phadke, R. Org. React. 1953, 7, 1.
24. 17. The relative configuration of all diastereomeric compounds was assigned by NOE experiments. Chiral compounds were prepared and tested as racemates.
25. 18. A complete description of these assays, including materials and methods, can be found in reference 4.
26. 19. Data not shown.
27. 20. This is consistent with related subseries; see ref. 4 and 9a.
28. 21. Hamann, L. G.; Mani, N. S.; Davis, R. L.; Wang, X.-N.; Marschke, K. B.; Jones, T. K. J. Med. Chem. 1999, 42, 210.
29. 22. Zhi, L.; Tegley, C. M.; Marschke, K. B.; Jones, T. K. Bioorg. Med. Chem. Lett. 1999, 9, 1009.